Hiromi Shimada

1.6k total citations
74 papers, 1.3k citations indexed

About

Hiromi Shimada is a scholar working on Rheumatology, Molecular Biology and Immunology. According to data from OpenAlex, Hiromi Shimada has authored 74 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 18 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Hiromi Shimada's work include Systemic Lupus Erythematosus Research (14 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pregnancy and Medication Impact (6 papers). Hiromi Shimada is often cited by papers focused on Systemic Lupus Erythematosus Research (14 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Pregnancy and Medication Impact (6 papers). Hiromi Shimada collaborates with scholars based in Japan, United States and Sweden. Hiromi Shimada's co-authors include Hisashi Matsuda, Johji Yamahara, Johji YAMAHARA, Masayuki Yoshikawa, Nobutoshi Murakami, Satoshi Yoshizumi, Toshiyuki Murakami, Osamu Muraoka, Hiroshi Shimoda and Masayuki YOSHIKAWA and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Annals of the Rheumatic Diseases.

In The Last Decade

Hiromi Shimada

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiromi Shimada Japan	17	575	355	223	191	176	74	1.3k
Jiaqing Cao China	24	852 1.5×	334 0.9×	245 1.1×	157 0.8×	174 1.0×	122	1.6k
Alamgeer Umme Habiba Hasan Pakistan	22	349 0.6×	394 1.1×	100 0.4×	162 0.8×	319 1.8×	100	1.3k
Hyun Sun Lee South Korea	25	931 1.6×	338 1.0×	128 0.6×	104 0.5×	238 1.4×	60	1.6k
Sunil Sharma India	21	419 0.7×	266 0.7×	183 0.8×	190 1.0×	143 0.8×	90	1.5k
Jin‐Bin Wu Taiwan	25	899 1.6×	641 1.8×	99 0.4×	220 1.2×	264 1.5×	71	1.9k
Sergio López Spain	25	593 1.0×	170 0.5×	225 1.0×	182 1.0×	47 0.3×	81	1.9k
Won‐Hwan Park South Korea	23	672 1.2×	319 0.9×	65 0.3×	111 0.6×	294 1.7×	100	1.6k
Toshiya Kuno Japan	31	826 1.4×	323 0.9×	71 0.3×	110 0.6×	122 0.7×	78	2.1k
Benny K.H. Tan Singapore	12	1.2k 2.1×	308 0.9×	150 0.7×	72 0.4×	270 1.5×	16	2.2k
Sheikh Tasduq Abdullah India	29	709 1.2×	390 1.1×	105 0.5×	140 0.7×	505 2.9×	69	2.1k

Countries citing papers authored by Hiromi Shimada

Since Specialization

Citations

This map shows the geographic impact of Hiromi Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromi Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromi Shimada more than expected).

Fields of papers citing papers by Hiromi Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromi Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromi Shimada. The network helps show where Hiromi Shimada may publish in the future.

Co-authorship network of co-authors of Hiromi Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromi Shimada. A scholar is included among the top collaborators of Hiromi Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromi Shimada. Hiromi Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimada, Hiromi, Tomohiro Kameda, S. Nakashima, et al.. (2023). Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus. Lupus. 32(7). 833–841. 1 indexed citations

Norikane, Takashi, Yuka Yamamoto, Hiromi Shimada, et al.. (2023). [18F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels. EJNMMI Research. 13(1). 15–15. 4 indexed citations

Nakashima, S., et al.. (2022). Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus. Scientific Reports. 12(1). 10175–10175. 6 indexed citations

Kameda, Tomohiro, Hiromi Shimada, S. Nakashima, et al.. (2022). Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study. Medicine. 101(42). e31288–e31288. 3 indexed citations

Shimada, Hiromi, S. Nakashima, Tomohiro Kameda, et al.. (2022). Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease. Clinical Rheumatology. 41(11). 3345–3353. 3 indexed citations

Ushio, Yusuke, Tomohiro Kameda, Hiromi Shimada, et al.. (2022). Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease. Dermatologic Therapy. 35(8). e15616–e15616. 4 indexed citations

Ushio, Yusuke, Tomohiro Kameda, S. Nakashima, et al.. (2022). Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report. Allergy Asthma and Clinical Immunology. 18(1). 84–84.

Shimada, Hiromi, et al.. (2022). AB0497 IMMUNOLOGICAL DISEASE ACTIVITY PARAMETERS AT CONCEPTION ARE RISK FACTORS FOR PRETERM BIRTH AND LOW BIRTH WEIGHT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 81. 1375–1376. 1 indexed citations

Shimada, Hiromi, Tomohiro Kameda, S. Nakashima, et al.. (2021). Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report. Allergy Asthma and Clinical Immunology. 17(1). 90–90. 4 indexed citations

10.

Kameda, Tomohiro, Hiroki Ozaki, S. Nakashima, et al.. (2020). Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab. Modern Rheumatology Case Reports. 5(1). 145–151. 8 indexed citations

11.

Kameda, Tomohiro, S. Nakashima, Hiromi Shimada, et al.. (2019). Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus. Lupus. 28(7). 826–833. 13 indexed citations

12.

Shimada, Hiromi, Tomohiro Kameda, Kenji Kanenishi, et al.. (2019). Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers. Clinical Rheumatology. 38(5). 1453–1458. 16 indexed citations

13.

Shimada, Hiromi. (2017). Standardization Activity of Digital Technical Product Documentation in JAMA. Journal of the Japan Society for Precision Engineering. 83(8). 727–731. 1 indexed citations

14.

Suzuki, Manzo, et al.. (2013). Perioperative very low-dose ketamine infusion actually increases the incidence of postoperative remifentanil-induced shivering–double-blind randomized trial. Acta anaesthesiologica Taiwanica. 51(4). 149–154. 1 indexed citations

15.

Yoshikawa, Masayuki, Hiromi Shimada, Norihisa Nishida, et al.. (1998). Antidiabetic Principles of Natural Medicines. II. Aldose Reductase and .ALPHA.-Glucosidase Inhibitors from Brazilian Natural Medicine, the Leaves of Myrcia multiflora DC. (Myrtaceae): Structures of Myrciacitrins I and II and Myrciaphenones A and B.. Chemical and Pharmaceutical Bulletin. 46(1). 113–119. 115 indexed citations

16.

YOSHIKAWA, Masayuki, Toshiyuki MURAKAMI, Hiromi Shimada, et al.. (1998). Medicinal Foodstuffs. XIV. On the Bioactive Constituents of Moroheiya. (2): New Fatty Acids, Corchorifatty Acids A, B, C, D, E, and F, from the Leaves of Corchorus olitorius L. (Tiliaceae): Structures and Inhibitory Effect on NO Production in Mouse Peritoneal Macrophages.. Chemical and Pharmaceutical Bulletin. 46(6). 1008–1014. 57 indexed citations

17.

Matsuda, Hisashi, et al.. (1997). Inhibitory Mechanisms of Oleanolic Acid 3-O-Monodesmosides on Glucose Absorption in Rats.. Biological and Pharmaceutical Bulletin. 20(6). 717–719. 25 indexed citations

18.

YOSHIKAWA, Masayuki, Hiromi Shimada, Hajime Komatsu, et al.. (1997). Medicinal Foodstuffs. VI. Histamine Release Inhibitors from Kidney Bean, the Seeds of Phaseolus vulgaris L.: Chemical Structures of Sandosaponins A and B.. Chemical and Pharmaceutical Bulletin. 45(5). 877–882. 16 indexed citations

19.

Yoshikawa, Masayuki, Yue Dai, Hiromi Shimada, et al.. (1997). Studies on Kochiae Fructus. II. On the Saponin Constituents from the Fruit of Chinese Kochia scoparia (Chenopodiaceae): Chemical Structures of Kochianosides I, II, III, and IV.. Chemical and Pharmaceutical Bulletin. 45(6). 1052–1055. 25 indexed citations

20.

YOSHIKAWA, Masayuki, et al.. (1997). Medicinal Foodstuffs. V. Moroheiya. (1): Absolute Stereostructures of Corchoionosides A, B, and C, Histamine Release lnhibitors from the Leaves of Vietnamese Corchorus olitorius L. (Tiliaceae).. Chemical and Pharmaceutical Bulletin. 45(3). 464–469. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact